全文获取类型
收费全文 | 3909篇 |
免费 | 268篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 77篇 |
儿科学 | 135篇 |
妇产科学 | 62篇 |
基础医学 | 485篇 |
口腔科学 | 89篇 |
临床医学 | 296篇 |
内科学 | 987篇 |
皮肤病学 | 123篇 |
神经病学 | 284篇 |
特种医学 | 236篇 |
外科学 | 580篇 |
综合类 | 43篇 |
预防医学 | 248篇 |
眼科学 | 49篇 |
药学 | 214篇 |
中国医学 | 12篇 |
肿瘤学 | 272篇 |
出版年
2023年 | 25篇 |
2022年 | 36篇 |
2021年 | 92篇 |
2020年 | 48篇 |
2019年 | 104篇 |
2018年 | 117篇 |
2017年 | 72篇 |
2016年 | 93篇 |
2015年 | 132篇 |
2014年 | 124篇 |
2013年 | 162篇 |
2012年 | 201篇 |
2011年 | 226篇 |
2010年 | 166篇 |
2009年 | 141篇 |
2008年 | 199篇 |
2007年 | 183篇 |
2006年 | 186篇 |
2005年 | 211篇 |
2004年 | 151篇 |
2003年 | 167篇 |
2002年 | 167篇 |
2001年 | 138篇 |
2000年 | 139篇 |
1999年 | 115篇 |
1998年 | 57篇 |
1997年 | 69篇 |
1996年 | 62篇 |
1995年 | 39篇 |
1994年 | 28篇 |
1993年 | 28篇 |
1992年 | 38篇 |
1991年 | 54篇 |
1990年 | 55篇 |
1989年 | 51篇 |
1988年 | 47篇 |
1987年 | 37篇 |
1986年 | 32篇 |
1985年 | 27篇 |
1984年 | 23篇 |
1983年 | 14篇 |
1982年 | 12篇 |
1981年 | 9篇 |
1980年 | 8篇 |
1979年 | 10篇 |
1978年 | 8篇 |
1977年 | 8篇 |
1976年 | 9篇 |
1973年 | 12篇 |
1972年 | 15篇 |
排序方式: 共有4192条查询结果,搜索用时 31 毫秒
81.
M. del Remedio Guna Serrano M. Dolores Ocete Mochón M. José Lahiguera M. Carmen Bresó Concepción Gimeno Cardona 《Enfermedades infecciosas y microbiología clínica》2013
The UNE-EN-ISO 15189:2007 standard defines the requirements for quality and competence that must be met by medical laboratories. These laboratories should use this international standard to develop their own quality management systems and to evaluate their own competencies; in turn, this standard will be used by accreditation bodies to confirm or recognize the laboratories’ competence. In clinical microbiology laboratories, application of the standard implies the implementation of the technical and specific management requirements that must be met to achieve optimal quality when carrying out microbiological tests. In Spain, accreditation is granted by the Spanish Accreditation Body (Entidad Nacional de Acreditación). This review aims to discuss the practical application of the standard's technical requirements in mycobacterial laboratory. Firstly, we define the scope of accreditation. Secondly, we specify how the items of the standard on personnel management, control of equipment, environmental facilities, method validation, internal controls and customer satisfaction surveys were developed and implemented in our laboratory. 相似文献
82.
83.
84.
K. Paszkowska‐Szczur R.J. Scott P. Serrano‐Fernandez A. Mirecka P. Gapska B. Górski C. Cybulski R. Maleszka M. Sulikowski L. Nagay J. Lubinski T. Dębniak 《International journal of cancer. Journal international du cancer》2013,133(5):1094-1100
Xeroderma pigmentosum is a rare autosomal recessive disease that is associated with a severe deficiency in nucleotide excision repair. The presence of a distinct the nucleotide excision repair (NER) mutation signature in melanoma suggests that perturbations in this critical repair process are likely to be involved with disease risk. We hypothesized that persons with polymorphic NER gene(s) are likely to have reduced NER activity and are consequently at an increased risk of melanoma development. We assessed the association between 94 SNPs within seven XP genes (XPA–XPG) and the melanoma risk in the Polish population. We genotyped 714 unselected melanoma patients and 1,841 healthy adults to determine if there were any polymorphisms differentially represented in the disease group. We found that a significantly decreased risk of melanoma was associated with the Xeroderma pigmentosum complementation (XPC) rs2228000_CT genotype (odds ratio [OR] = 0.15; p < 0.001) and the rs2228000_TT genotype (OR = 0.11; p < 0.001) compared to the reference genotype. Haplotype analysis within XPC revealed the rs2228001_A + G1475A_G + G2061A_A + rs2228000_T + rs3731062_C haplotype (OR = 0.26; p < 0.05) was associated with a significantly decreased disease risk. The haplotype analysis within the Xeroderma pigmentosum group D (XPD) showed a modest association between two haplotypes and a decrease in melanoma risk. There were no major differences between the prevalence of the XP polymorphisms among young or older patients with melanoma. Linkage disequilibrium of XPC: rs2228001, G1475A, G2061A, rs2228000 and rs3731062 was found. The data from our study support the notion that only XPC and XPD genes are associated with melanoma susceptibility. 相似文献
85.
Rafael Fernandez Jose Manuel Serrano Isabel Umaran Ricard Abizanda Andres Carrillo Mª Jesus Lopez-Pueyo Pedro Rascado Begoña Balerdi Borja Suberviola Gonzalo Hernandez 《Intensive care medicine》2010,36(7):1196-1201
Background
Tools for predicting post-ICU patients’ outcomes are scarce. A single-center study showed that the Sabadell score classified patients into four groups with clear-cut differences in ward mortality. 相似文献86.
A monokine regulates colony-stimulating activity production by vascular endothelial cells 总被引:20,自引:0,他引:20
Human umbilical vein endothelial cells were cultured in supernatants of peripheral blood monocytes that had been cultured for 3 days with and without lactoferrin. Colony-stimulating activity (CSA) was measured in supernatants of the endothelial cell cultures and appropriate control cultures using normal, T-lymphocyte-depleted, phagocyte-depleted, low- density bone marrow cells in colony growth (CFU-GM) assays. Monocyte- conditioned medium contained a nondialyzable, heat labile factor that enhanced 4-15--fold the production of CSA by endothelial cells. The addition of lactoferrin to monocyte cultures reduced the activity of this monokine by 69%. Lactoferrin did not inhibit CSA production by monokine-stimulated endothelial cells. Therefore, vascular endothelial cells are potent sources of CSA, the production of CSA by these cells is regulated by a stimulatory monokine, and the production and/or release of the monokine is inhibited by lactoferrin, a neutrophil- derived putative feedback inhibitor of granulopoiesis. Inasmuch as a similar monokine is known to stimulate CSA production by fibroblasts and T lymphocytes, we suggest that mononuclear phagocytes play a pivotal role in the regulation of granulopoiesis by recruiting a variety of cell types to produce CSA. 相似文献
87.
Diego Dantas Almeida Vincent Louis Viala Pedro Gabriel Nachtigall Michael Broe H. Lisle Gibbs Solange Maria de Toledo Serrano Ana Maria Moura-da-Silva Paulo Lee Ho Milton Yutaka Nishiyama-Jr Incio L. M. Junqueira-de-Azevedo 《Proceedings of the National Academy of Sciences of the United States of America》2021,118(20)
88.
Fernández-Rodriguez CM Gutiérrez ML Serrano PL Lledó JL Santander C Fernández TP Tomás E Cacho G Nevado M Casas ML 《Digestive diseases and sciences》2004,49(11-12):1971-1976
Alcohol consumption, age at infection, and male gender have been identified as risk factors for faster fibrosis progression in patients with chronic hepatitis C (CHC). Yet the influence of liver steatosis, light to moderate alcohol consumption, or iron overload on this progression remains controversial. To analyze the effect of individual risk factors and their interaction on fibrosis progression in a group of patients with CHC and a definite date of infection, we studied 133 consecutive untreated patients. Covariates included were age, body mass index (BMI), gender, age at infection, alcohol intake, serum lipids, glycemia, serum ALT, AST, GGT, iron, and ferritin, grade and stage (METAVIR and Scheuer), and hepatic stainable iron (Perl's stain). The rate of fibrosis progression was inferred from the METAVIR score. By logistic regression analysis, hepatic steatosis (odds ratio [OR], 3.035; 95% confidence interval [CI], 1.16-7.93), serum ferritin levels higher than 290 ng/ml (OR, 5.5; 1.6-18.65), and light to moderate ethanol intake (1-50 g/day) (OR, 5.22; 1.5-17.67) were independently associated with faster fibrosis progression. There was no effect of interaction between these variables on the rate of fibrosis progression. Liver steatosis, serum ferritin levels, and light to moderate alcohol intake are associated with faster fibrosis progression in chronic hepatitis C. Combination of these factors did not further accelerate this progression. The impact of modification of these factors on progression should be tested in longitudinal studies. 相似文献
89.
再发骨质疏松性椎体压缩骨折保守治疗患者出院后生存质量 总被引:1,自引:0,他引:1
目的:对比初次和再发骨质疏松性椎体压缩骨折(osteoporotic vertebral compression fractures,OVCFs)患者保
守治疗的生存质量,了解再次骨折对此类患者生存质量各方面的影响。方法:回顾性观察治疗OVCFs后出现再骨折
的患者30名(再骨折组)和同时期行保守治疗OVCFs后未发生再骨折的基本条件相似的患者30例(对照组),比较两组出
院后3个月时SF-36简明健康健康状况调查表的调查结果。结果:再骨折组治疗后的8个维度均不同程度较对照组变差
(均P<0.01)。结论:再骨折组患者的生存质量明显低于对照组,并且会进一步影响患者的心理预期、情绪和社会活动
的各个方面。 相似文献